| 1 |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
Sarah S. Kalia, Kathy Adelman, Sherri J. Bale et al. · Genetics in Medicine
Open access |
17 Nov 2016 |
1,725 |
| 2 |
Breast Cancer Screening for Women at Average Risk
Kevin Charles Oeffinger, Elizabeth T. H. Fontham, Ruth Etzioni et al. · JAMA
Open access |
20 Oct 2015 |
1,670 |
| 3 |
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou Constance Dueck et al. · JAMA Oncology
Open access |
13 Aug 2015 |
1,045 |
| 4 |
Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer
Kathryn H. Schmitz et al. · CA A Cancer Journal for Clinicians
Open access |
16 Oct 2019 |
825 |
| 5 |
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi Balzer Haas et al. · The Lancet
Open access |
8 Mar 2016 |
644 |
| 6 |
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network
Open access |
Mar 2020 |
638 |
| 7 |
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Pamela L. Kunz, Diane L. Reidy‐Lagunes, Lowell Brian Anthony et al. · Pancreas
Open access |
16 Apr 2013 |
589 |
| 8 |
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Nadeem R. Abu‐Rustum et al. · Journal of the National Comprehensive Cancer Network
|
Feb 2023 |
578 |
| 9 |
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network
Open access |
Apr 2023 |
570 |
| 10 |
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
David T. Miller, Kristy Lee, Wendy K. Chung et al. · Genetics in Medicine
Open access |
20 May 2021 |
570 |
| 11 |
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Nasser H. Hanna et al. · Journal of Clinical Oncology
|
28 Jan 2020 |
458 |
| 12 |
United States Valuation of EQ-5D-5L Health States Using an International Protocol
Alan Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health
Open access |
25 May 2019 |
404 |
| 13 |
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Nadeem R. Abu‐Rustum et al. · Journal of the National Comprehensive Cancer Network
Open access |
Dec 2023 |
386 |
| 14 |
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
Arvind N. Dasari et al. · Nature Reviews Clinical Oncology
ReviewOpen access |
6 Jul 2020 |
380 |
| 15 |
Assessing research gaps and unmet needs in endometriosis
Sawsan As‐Sanie, Rebecca Black, Linda C. Giudice et al. · American Journal of Obstetrics and Gynecology
|
18 Feb 2019 |
355 |
| 16 |
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021
Daniel Aaron Pollyea et al. · Journal of the National Comprehensive Cancer Network
|
6 Jan 2021 |
333 |
| 17 |
Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline
Mary T. Korytkowski, Ranganath Muniyappa, Kellie Antinori-Lent et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
12 Jun 2022 |
306 |
| 18 |
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
Robert J. Fox et al. · New England Journal of Medicine
Open access |
29 Aug 2018 |
291 |
| 19 |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
David T. Miller, Kristy Lee, ALLAN S. GORDON et al. · Genetics in Medicine
Open access |
20 May 2021 |
277 |
| 20 |
Bladder Cancer, Version 3.2024
Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network
|
May 2024 |
267 |
| 21 |
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
Luciano J. Costa, Saurabh Chhabra, Eva Medvedova et al. · Journal of Clinical Oncology
|
13 Dec 2021 |
266 |
| 22 |
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement
Randall A. Oyer et al. · Journal of Clinical Oncology
|
19 May 2022 |
251 |
| 23 |
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
Mark D. Stewart et al. · The Oncologist
Open access |
2022 |
240 |
| 24 |
The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation
David A. Ginsberg, Timothy B. Boone, Anne Pelletier Cameron et al. · The Journal of Urology
|
8 Sep 2021 |
223 |
| 25 |
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W. Flaig et al. · Journal of the National Comprehensive Cancer Network
Open access |
Sep 2018 |
220 |
| 26 |
Pilot Feasibility Study of an Oncology Financial Navigation Program
Veena Shankaran, Tony Leahy, Jordan Steelquist et al. · Journal of Oncology Practice
|
22 Dec 2017 |
217 |
| 27 |
British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults
Anjan Dhar, Hasan Haboubi, Stephen Attwood et al. · Gut
Open access |
23 May 2022 |
214 |
| 28 |
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Jaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network
|
May 2025 |
203 |
| 29 |
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
Antonio Passaro et al. · Annals of Oncology
Open access |
14 Feb 2022 |
203 |
| 30 |
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
Shaji Kunnathu Kumar et al. · Journal of the National Comprehensive Cancer Network
Open access |
2018 |
203 |
| 31 |
Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group
Satkiran S. Grewal, Thomas E. Merchant, Renee Reymond et al. · PEDIATRICS
Open access |
2 Mar 2010 |
203 |
| 32 |
Physician Workforce Disparities and Patient Care: A Narrative Review
Julie K. Silver, Allison Bean, Chloe S. Slocum et al. · Health Equity
ReviewOpen access |
Jul 2019 |
199 |
| 33 |
Real-Time Continuous Glucose Monitoring in Type 1 Diabetes: A Qualitative Framework Analysis of Patient Narratives
John C. Pickup, Melissa Holloway, Kritika Samsi · Diabetes Care
|
31 Dec 2014 |
192 |
| 34 |
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update
Oscar Roberto Brouwer et al. · European Urology
|
9 Mar 2023 |
188 |
| 35 |
Informed Consent in the Medical Care of Transgender and Gender-Nonconforming Patients
Timothy Cavanaugh, Ruben A. Hopwood, Cei Lambert · The AMA Journal of Ethic
Open access |
Nov 2016 |
188 |
| 36 |
Changing the global obesity narrative to recognize and reduce weight stigma: A position statement from the World Obesity Federation
Sarah Nutter et al. · Obesity Reviews
Open access |
17 Oct 2023 |
184 |
| 37 |
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
Sharon Hermes Giordano, Maria Alice Franzoi, Sarah Temin et al. · Journal of Clinical Oncology
Open access |
31 May 2022 |
184 |
| 38 |
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
Julia Bohlius, Kari Bohlke, Roberto Castelli et al. · Blood Advances
Open access |
10 Apr 2019 |
167 |
| 39 |
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Shaji Kunnathu Kumar et al. · Journal of the National Comprehensive Cancer Network
Open access |
Dec 2023 |
157 |
| 40 |
The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up
David A. Ginsberg, Timothy B. Boone, Anne Pelletier Cameron et al. · The Journal of Urology
|
8 Sep 2021 |
156 |
| 41 |
NCCN Guidelines® Insights: Distress Management, Version 2.2023
Michelle B. Riba et al. · Journal of the National Comprehensive Cancer Network
Open access |
May 2023 |
142 |
| 42 |
Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: points to consider
Amy L. McGuire, Rebecca E. Fisher, Paul Cusenza et al. · Genetics in Medicine
Open access |
Jul 2008 |
138 |
| 43 |
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
John A. Thompson et al. · Journal of the National Comprehensive Cancer Network
|
Nov 2024 |
136 |
| 44 |
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
Navneet Singh et al. · Journal of Clinical Oncology
|
11 Jul 2022 |
131 |
| 45 |
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Joyce F. Liu et al. · Journal of the National Comprehensive Cancer Network
|
Oct 2024 |
126 |
| 46 |
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Luciano J. Costa et al. · Leukemia
Open access |
11 Aug 2020 |
125 |
| 47 |
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
Brian I. Rini, David F. McDermott, Hans J. Hammers et al. · Journal for ImmunoTherapy of Cancer
Open access |
11 Nov 2016 |
122 |
| 48 |
Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer's disease
Michelle M. Mielke et al. · Alzheimer s & Dementia
Open access |
Oct 2024 |
117 |
| 49 |
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
Navneet Singh et al. · Journal of Clinical Oncology
|
11 Jul 2022 |
116 |
| 50 |
Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence
Stephen E. Nadeau, Jeffrey K. Wu, Richard A Lawhern · Frontiers in Pain Research
Open access |
17 Aug 2021 |
108 |